共 211 条
[21]
Taketa T(2018)Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma Eur J Nucl Med Mol Imaging 45 1752-15
[22]
Cooper JS(2020)Development and validation of a radiomics signature on differentially expressed features of (18)F-FDG PET to predict treatment response of concurrent chemoradiotherapy in thoracic esophagus squamous cell carcinoma Radiother Oncol 146 9-47
[23]
Guo MD(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer. 45 228-86
[24]
Herskovic A(2021)Usefulness of [(68)Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [(18)F]FDG PET/CT findings Eur J Nucl Med Mol Imaging 48 73-1491
[25]
Macdonald JS(2020)Usefulness of [(18)F]fluorodeoxyglucose PET/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma Eur J Nucl Med Mol Imaging 79 1485-3617
[26]
Martenson JA(2020)Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging Ann Rheum Dis 48 3606-1373
[27]
Al-Sarraf M(2021)Clinical utility of [(68)Ga]Ga-labeled fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography for primary staging and recurrence detection in nasopharyngeal carcinoma Eur J Nucl Med Mol Imaging 18 35-1740
[28]
Mendelsohn J(2018)Accurate FDG PET tumor segmentation using the peritumoral halo layer method: a study in patients with esophageal squamous cell carcinoma Cancer Imaging 15 1369-63
[29]
Rice TW(2014)Pre-treatment metabolic tumor volume and total lesion glycolysis are useful prognostic factors for esophageal squamous cell cancer patients Asian Pac J Cancer Prev 34 1722-237
[30]
Apperson-Hansen C(2014)New TNM staging system for esophageal cancer: what chest radiologists need to know Radiographics 21 947-1020